Hodgkin's lymphoma in adults- diagnosis and treatment

被引：0

作者：

Gruszczynska, Anna ^{[1
]}

Kowalik, Krzysztof ^{[2
]}

Jablonska, Dagmara ^{[3
]}

Hetman, Katarzyna ^{[4
]}

Modrzejewski, Andrzej ^{[2
]}

机构：

[1] Pomeranian Med Univ, Dept Forens Med, Szczecin, Poland

[2] Pomeranian Med Univ, Clin Dept Gen Surg, Szczecin, Poland

[3] Reg Hosp Kielce, Clin Dept Nephrol, Dialysis Stn, Kielce, Poland

[4] Western Pomeranian Oncol Ctr Szczecin, Dept Clin Oncol, 22 Strzalowska St, PL-71730 Szczecin, Poland

来源：

FAMILY MEDICINE AND PRIMARY CARE REVIEW | 2024年 / 26卷 / 02期

关键词：

Hodgkin disease; diagnosis; treatment; drug therapy; STEM-CELL-TRANSPLANTATION; INVOLVED-FIELD RADIOTHERAPY; TERM-FOLLOW-UP; INTERNATIONAL PROGNOSTIC SCORE; HIGH-DOSE CHEMOTHERAPY; DETUDE DES LYMPHOMES; 2ND CANCER-RISK; EARLY-STAGE; BRENTUXIMAB VEDOTIN; SINGLE-ARM;

D O I：

10.5114/fmpcr.2024.139038

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Hodgkin's lymphoma (HL) is a malignant disease of the lymphatic system with two peaks of incidence. Often one of the first symptoms of the disease is non -painful enlargement of the lymph nodes. The development of diagnostic techniques has allowed more efficient evaluation of the lesions. Classification of patients according to stage and the presence of risk factors has made it possible to tailor treatment regimes to the individual patient. The article discusses the diagnosis and contemporary treatment options for HL.

引用

页码：251 / 260

页数：10

共 167 条

[1] Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? [J].

Adams, H. J. A. ;

Kwee, T. C. ;

de Keizer, B. ;

Fijnheer, R. ;

de Klerk, J. M. H. ;

Littooij, A. S. ;

Nievelstein, R. A. J. .

ANNALS OF ONCOLOGY, 2014, 25 (05) :921-927

[2] Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma [J].

Advani, Ranjana H. ;

Horning, Sandra J. ;

Hoppe, Richard T. ;

Daadi, Sarah ;

Allen, John ;

Natkunam, Yasodha ;

Bartlett, Nancy L. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) :912-+

[3] The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study [J].

Agostinelli, Claudio ;

Gallamini, Andrea ;

Stracqualursi, Luisa ;

Agati, Patrizia ;

Tripodo, Claudio ;

Fuligni, Fabio ;

Sista, Maria Teresa ;

Fanti, Stefano ;

Biggi, Alberto ;

Vitolo, Umberto ;

Rigacci, Luigi ;

Merli, Francesco ;

Patti, Caterina ;

Romano, Alessandra ;

Levis, Alessandro ;

Trentin, Livio ;

Stelitano, Caterina ;

Borra, Anna ;

Piccaluga, Pier Paolo ;

Hamilton-Dutoit, Stephen ;

Kamper, Peter ;

Zaucha, Jan Maciej ;

Malkowski, Bogdan ;

Kulikowski, Waldemar ;

Tajer, Joanna ;

Subocz, Edyta ;

Rybka, Justyna ;

Steidl, Christian ;

Broccoli, Alessandro ;

Argnani, Lisa ;

Gascoyne, Randy D. ;

d'Amore, Francesco ;

Zinzani, Pier Luigi ;

Pileri, Stefano A. .

LANCET HAEMATOLOGY, 2016, 3 (10) :E467-E479

[4] Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation [J].

Akhtari, Mani ;

Milgrom, Sarah A. ;

Pinnix, Chelsea C. ;

Reddy, Jay P. ;

Dong, Wenli ;

Smith, Grace L. ;

Mawlawi, Osama ;

Abou Yehia, Zeinab ;

Gunther, Jillian ;

Osborne, Eleanor M. ;

Andraos, Therese Y. ;

Wogan, Christine F. ;

Rohren, Eric ;

Garg, Naveen ;

Chuang, Hubert ;

Khoury, Joseph D. ;

Oki, Yasuhiro ;

Fanale, Michelle ;

Dabaja, Bouthaina S. .

BLOOD, 2018, 131 (01) :84-94

[5] Involved-field radiotherapy for advanced Hodgkin's lymphoma [J].

Aleman, BMP ;

Raemaekers, JMM ;

Tirelli, U ;

Bortolus, R ;

van't Veer, MB ;

Lybeert, MLM ;

Keuning, JJ ;

Carde, P ;

Girinsky, T ;

van der Maazen, RWM ;

Tomsic, R ;

Vovk, M ;

van Hoof, A ;

Demeestere, G ;

Lugtenburg, PJ ;

Thomas, J ;

Schroyens, W ;

De Boeck, K ;

Baars, JW ;

Kluin-Nelemans, JC ;

Carrie, C ;

Aoudjhane, M ;

Bron, D ;

Eghbali, H ;

Smit, WGJM ;

Meerwaldt, JH ;

Hagenbeek, A ;

Pinna, A ;

Henry-Amar, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) :2396-2406

[6] Long-term cause-specific mortality of patients treated for Hodgkin's disease [J].

Aleman, BMP ;

van den Belt-Dusebout, AW ;

Klokman, WJ ;

van't Veer, MB ;

Bartelink, H ;

van Leeuwen, FE .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) :3431-3439

[7] Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: Prior infection by EBV and other agents [J].

Alexander F.E. ;

Jarrett R.F. ;

Lawrence D. ;

Armstrong A.A. ;

Freeland J. ;

Gokhale D.A. ;

Kane E. ;

Taylor G.M. ;

Wright D.H. ;

Cartwright R.A. .

British Journal of Cancer, 2000, 82 (5) :1117-1121

[8]

American Cancer Society, 2022, CANC FACTS FIGURES 2

[9] Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial [J].

Andre, Marc P. E. ;

Girinsky, Theodore ;

Federico, Massimo ;

Reman, Oumedaly ;

Fortpied, Catherine ;

Gotti, Manuel ;

Casasnovas, Olivier ;

Brice, Pauline ;

van der Maazen, Richard ;

Re, Alessandro ;

Edeline, Veronique ;

Ferme, Christophe ;

van Imhoff, Gustaaf ;

Merli, Francesco ;

Bouabdallah, Reda ;

Sebban, Catherine ;

Specht, Lena ;

Stamatoullas, Aspasia ;

Delarue, Richard ;

Fiaccadori, Valeria ;

Bellei, Monica ;

Raveloarivahy, Tiana ;

Versari, Annibale ;

Hutchings, Martin ;

Meignan, Michel ;

Raemaekers, John .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (16) :1786-+

[10] HODGKINS-DISEASE DURING HIV-1 INFECTION - THE FRENCH REGISTRY EXPERIENCE [J].

ANDRIEU, JM ;

ROITHMANN, S ;

TOURANI, JM ;

LEVY, R ;

DESABLENS, B ;

LEMAIGNAN, C ;

GASTAUT, JA ;

BRICE, P ;

RAPHAEL, M ;

TAILLAN, B .

ANNALS OF ONCOLOGY, 1993, 4 (08) :635-641

← 1 2 3 4 5 6 7 8 9 10 →